Global Recombinant Protein Drug Market Research Report 2022 - Market Size, Current Insights and Development Trends

Published: January 2023

No. of Pages: 98

Price:

Single User License: US $ 3450

Corporate User License: US $ 6900

Report Description
Table of Contents

The report focuses on the Recombinant Protein Drug market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Recombinant Protein Drug market.

Major Players in the Recombinant Protein Drug market are:
NCPC
Merck Serono
Eli Lilly
Roche
SL PHARM
Changchun High & New Technology Industry
Amgen
Shenzhen Neptunus Interlong Bio-Technique
Heng Rui
Ortho Biotech
Anhui Anke Biotechnology
Sanofi
Novo Nordisk
Livzon Pharmaceutical
Pharmingen
GenSci
Abcam
Kyowa Hakko Kirin

On the basis of types, the Recombinant Protein Drug market is primarily split into:
Recombinant Insulin
Recombinant Human Interferon (rhIFN)
Recombinant Human Erythropoietin (rhEPO)
Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF)
Recombinant Human Growth Hormone (rhGH)
Recombinant Human Follicle-stimulating Hormone (rhFSH)
Others

On the basis of applications, the market covers:
Hospital use
Clinic use
Household

Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others

Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029

Table of Content

1 Recombinant Protein Drug Market Overview
1.1 Product Overview and Scope of Recombinant Protein Drug Market
1.2 Recombinant Protein Drug Market Segment by Type
1.2.1 Global Recombinant Protein Drug Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Recombinant Protein Drug Market Segment by Application
1.3.1 Recombinant Protein Drug Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Recombinant Protein Drug Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Recombinant Protein Drug (2017-2029)
1.5.1 Global Recombinant Protein Drug Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Recombinant Protein Drug Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Recombinant Protein Drug Industry
1.7 Impact of Carbon Neutrality on the Recombinant Protein Drug Industry

2 Recombinant Protein Drug Market Upstream and Downstream Analysis
2.1 Recombinant Protein Drug Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Recombinant Protein Drug Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream

3 Players Profiles
3.1 NCPC
3.1.1 NCPC Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Recombinant Protein Drug Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Merck Serono
3.2.1 Merck Serono Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Recombinant Protein Drug Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Eli Lilly
3.3.1 Eli Lilly Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Recombinant Protein Drug Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Roche
3.4.1 Roche Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Recombinant Protein Drug Market Performance (2017-2022)
3.4.4 Business Overview
3.5 SL PHARM
3.5.1 SL PHARM Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Recombinant Protein Drug Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Changchun High & New Technology Industry
3.6.1 Changchun High & New Technology Industry Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Recombinant Protein Drug Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Amgen
3.7.1 Amgen Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Recombinant Protein Drug Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Shenzhen Neptunus Interlong Bio-Technique
3.8.1 Shenzhen Neptunus Interlong Bio-Technique Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Recombinant Protein Drug Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Heng Rui
3.9.1 Heng Rui Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Recombinant Protein Drug Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Ortho Biotech
3.10.1 Ortho Biotech Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Recombinant Protein Drug Market Performance (2017-2022)
3.10.4 Business Overview
3.11 Anhui Anke Biotechnology
3.11.1 Anhui Anke Biotechnology Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 Recombinant Protein Drug Market Performance (2017-2022)
3.11.4 Business Overview
3.12 Sanofi
3.12.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 Recombinant Protein Drug Market Performance (2017-2022)
3.12.4 Business Overview
3.13 Novo Nordisk
3.13.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Product Profiles, Application and Specification
3.13.3 Recombinant Protein Drug Market Performance (2017-2022)
3.13.4 Business Overview
3.14 Livzon Pharmaceutical
3.14.1 Livzon Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Product Profiles, Application and Specification
3.14.3 Recombinant Protein Drug Market Performance (2017-2022)
3.14.4 Business Overview
3.15 Pharmingen
3.15.1 Pharmingen Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Product Profiles, Application and Specification
3.15.3 Recombinant Protein Drug Market Performance (2017-2022)
3.15.4 Business Overview
3.16 GenSci
3.16.1 GenSci Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Product Profiles, Application and Specification
3.16.3 Recombinant Protein Drug Market Performance (2017-2022)
3.16.4 Business Overview
3.17 Abcam
3.17.1 Abcam Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Product Profiles, Application and Specification
3.17.3 Recombinant Protein Drug Market Performance (2017-2022)
3.17.4 Business Overview
3.18 Kyowa Hakko Kirin
3.18.1 Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Product Profiles, Application and Specification
3.18.3 Recombinant Protein Drug Market Performance (2017-2022)
3.18.4 Business Overview

4 Global Recombinant Protein Drug Market Landscape by Player
4.1 Global Recombinant Protein Drug Sales and Share by Player (2017-2022)
4.2 Global Recombinant Protein Drug Revenue and Market Share by Player (2017-2022)
4.3 Global Recombinant Protein Drug Average Price by Player (2017-2022)
4.4 Global Recombinant Protein Drug Gross Margin by Player (2017-2022)
4.5 Recombinant Protein Drug Market Competitive Situation and Trends
4.5.1 Recombinant Protein Drug Market Concentration Rate
4.5.2 Recombinant Protein Drug Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion

5 Global Recombinant Protein Drug Sales, Revenue, Price Trend by Type
5.1 Global Recombinant Protein Drug Sales and Market Share by Type (2017-2022)
5.2 Global Recombinant Protein Drug Revenue and Market Share by Type (2017-2022)
5.3 Global Recombinant Protein Drug Price by Type (2017-2022)
5.4 Global Recombinant Protein Drug Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Recombinant Protein Drug Sales, Revenue and Growth Rate of Recombinant Insulin (2017-2022)
5.4.2 Global Recombinant Protein Drug Sales, Revenue and Growth Rate of Recombinant Human Interferon (rhIFN) (2017-2022)
5.4.3 Global Recombinant Protein Drug Sales, Revenue and Growth Rate of Recombinant Human Erythropoietin (rhEPO) (2017-2022)
5.4.4 Global Recombinant Protein Drug Sales, Revenue and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) (2017-2022)
5.4.5 Global Recombinant Protein Drug Sales, Revenue and Growth Rate of Recombinant Human Growth Hormone (rhGH) (2017-2022)
5.4.6 Global Recombinant Protein Drug Sales, Revenue and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH) (2017-2022)
5.4.7 Global Recombinant Protein Drug Sales, Revenue and Growth Rate of Others (2017-2022)

6 Global Recombinant Protein Drug Market Analysis by Application
6.1 Global Recombinant Protein Drug Consumption and Market Share by Application (2017-2022)
6.2 Global Recombinant Protein Drug Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Recombinant Protein Drug Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Recombinant Protein Drug Consumption and Growth Rate of Hospital use (2017-2022)
6.3.2 Global Recombinant Protein Drug Consumption and Growth Rate of Clinic use (2017-2022)
6.3.3 Global Recombinant Protein Drug Consumption and Growth Rate of Household (2017-2022)

7 Global Recombinant Protein Drug Sales and Revenue Region Wise (2017-2022)
7.1 Global Recombinant Protein Drug Sales and Market Share, Region Wise (2017-2022)
7.2 Global Recombinant Protein Drug Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Recombinant Protein Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Recombinant Protein Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Recombinant Protein Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Recombinant Protein Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Recombinant Protein Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Recombinant Protein Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Recombinant Protein Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Recombinant Protein Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Recombinant Protein Drug Sales, Revenue, Price and Gross Margin (2017-2022)

8 Global Recombinant Protein Drug Market Forecast (2022-2029)
8.1 Global Recombinant Protein Drug Sales, Revenue Forecast (2022-2029)
8.1.1 Global Recombinant Protein Drug Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Recombinant Protein Drug Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Recombinant Protein Drug Price and Trend Forecast (2022-2029)
8.2 Global Recombinant Protein Drug Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Recombinant Protein Drug Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Recombinant Protein Drug Sales and Revenue Forecast (2022-2029)
8.2.3 China Recombinant Protein Drug Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Recombinant Protein Drug Sales and Revenue Forecast (2022-2029)
8.2.5 India Recombinant Protein Drug Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Recombinant Protein Drug Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Recombinant Protein Drug Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Recombinant Protein Drug Sales and Revenue Forecast (2022-2029)
8.3 Global Recombinant Protein Drug Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Insulin (2022-2029)
8.3.2 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Human Interferon (rhIFN) (2022-2029)
8.3.3 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Human Erythropoietin (rhEPO) (2022-2029)
8.3.4 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) (2022-2029)
8.3.5 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Human Growth Hormone (rhGH) (2022-2029)
8.3.6 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH) (2022-2029)
8.3.7 Global Recombinant Protein Drug Revenue and Growth Rate of Others (2022-2029)
8.4 Global Recombinant Protein Drug Consumption Forecast by Application (2022-2029)
8.4.1 Global Recombinant Protein Drug Consumption Value and Growth Rate of Hospital use (2022-2029)
8.4.2 Global Recombinant Protein Drug Consumption Value and Growth Rate of Clinic use (2022-2029)
8.4.3 Global Recombinant Protein Drug Consumption Value and Growth Rate of Household (2022-2029)
8.5 Recombinant Protein Drug Market Forecast Under COVID-19

9 Industry Outlook
9.1 Recombinant Protein Drug Market Drivers Analysis
9.2 Recombinant Protein Drug Market Restraints and Challenges
9.3 Recombinant Protein Drug Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Recombinant Protein Drug Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Recombinant Protein Drug Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Recombinant Protein Drug Industry Development

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source

Write comment about above report:

Published By: Maia Research

Product Code: Maia Research820109

Related Reports

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Global and China Recombinant Protein Drug R&D Market Size, Status and Forecast 2021-2027 Global Recombinant Protein Drug R&D Scope and Market Size Recombinant Protein Drug R&D market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Prote...
Global Recombinant Protein Drug R&D Market Size, Status and Forecast 2021-2027 Market Analysis and Insights: Global Recombinant Protein Drug R&D Market The global Recombinant Protein Drug R&D market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. W...
Global Recombinant Protein Drug Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread) The Recombinant Protein Drug market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Recombinant Protein Drug market report is a comprehensive research that focuses ...
Global Recombinant Protein Drug R&D Market Size, Status and Forecast 2020-2026 Recombinant Protein Drug R&D market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Protein Drug R&D market will be able to gain the upper hand as they us...

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *